Dupont Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Dupont Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13,332	Closed	-$904K	–	1335
2019 Q3	$904K	Sell	13,332 -14,839	-53%	-$1.02M	0.02%	556
2019 Q2	$1.64M	Sell	28,171 -11,065	-28%	-$655K	0.04%	413
2019 Q1	$2.75M	Buy	39,236 +11,065	+39%	+$820K	0.06%	291
2018 Q4	$1.81M	Sell	28,171 -4,082	-13%	-$286K	0.04%	378
2018 Q3	$2.27M	Hold	32,253	–	–	0.05%	348
2018 Q2	$1.63M	Hold	32,253	–	–	0.04%	434
2018 Q1	$1.01M	Hold	32,253	–	–	0.02%	512
2017 Q4	$1.1M	Buy	+32,253	New	+$1.03M	0.03%	497

Dupont Capital Management's GHDX Position: Q4 2019 in Review

Dupont Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 13,332 shares — an estimated $904K sold.

Dupont Capital Management first reported a position in GHDX in Q4 2017 and held it in 8 quarters. The position peaked at $2.75M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Dupont Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Dupont Capital Management sold 13,332 Genomic Health, Inc. shares in Q4 2019, an estimated $904K.
Dupont Capital Management first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 8 quarters.
Dupont Capital Management's Genomic Health, Inc. position peaked at $2.75M in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Dupont Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.